147 related articles for article (PubMed ID: 19211977)
1. Detrimental effect of postnatal blockade of N-methyl-D-aspartate receptors on sensorimotor gating is reversed by neuroleptic drugs.
Wedzony K; Fijał K; Maćkowiak M; Chocyk A
Pharmacol Rep; 2008; 60(6):856-64. PubMed ID: 19211977
[TBL] [Abstract][Full Text] [Related]
2. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W
Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025
[TBL] [Abstract][Full Text] [Related]
3. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
4. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
Duncan GE; Moy SS; Lieberman JA; Koller BH
Pharmacol Biochem Behav; 2006 Nov; 85(3):481-91. PubMed ID: 17097724
[TBL] [Abstract][Full Text] [Related]
5. Fear memory in a neurodevelopmental model of schizophrenia based on the postnatal blockade of NMDA receptors.
Latusz J; Radaszkiewicz A; Bator E; Wędzony K; Maćkowiak M
Pharmacol Rep; 2017 Feb; 69(1):71-76. PubMed ID: 27907838
[TBL] [Abstract][Full Text] [Related]
6. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine.
Bast T; Zhang WN; Heidbreder C; Feldon J
Neuroscience; 2001; 103(2):325-35. PubMed ID: 11246148
[TBL] [Abstract][Full Text] [Related]
7. Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine.
Hudson MR; Rind G; O'Brien TJ; Jones NC
Transl Psychiatry; 2016 Apr; 6(4):e784. PubMed ID: 27093066
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats.
Wedzony K; Gołembiowska K; Zazula M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):555-62. PubMed ID: 7870195
[TBL] [Abstract][Full Text] [Related]
9. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats.
Ossowska K; Pietraszek M; Wardas J; Nowak G; Wolfarth S
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):280-7. PubMed ID: 10344526
[TBL] [Abstract][Full Text] [Related]
10. The effect of a full agonist/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats.
Bubenikova-Valesova V; Svoboda J; Horacek J; Vales K
Int J Neuropsychopharmacol; 2009 Aug; 12(7):873-83. PubMed ID: 19154630
[TBL] [Abstract][Full Text] [Related]
11. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
Wedzony K; Czyrak A; Maćkowiak M; Fijał K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
[TBL] [Abstract][Full Text] [Related]
12. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
[TBL] [Abstract][Full Text] [Related]
13. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
Linn GS; Negi SS; Gerum SV; Javitt DC
Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
[TBL] [Abstract][Full Text] [Related]
14. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.
Swerdlow NR; Bakshi V; Waikar M; Taaid N; Geyer MA
Psychopharmacology (Berl); 1998 Nov; 140(1):75-80. PubMed ID: 9862405
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.
Geyer MA; Krebs-Thomson K; Braff DL; Swerdlow NR
Psychopharmacology (Berl); 2001 Jul; 156(2-3):117-54. PubMed ID: 11549216
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
[TBL] [Abstract][Full Text] [Related]
18. Effects of early postnatal MK-801 treatment on behavioral properties in rats: Differences according to treatment schedule.
Kawabe K; Miyamoto E
Behav Brain Res; 2019 Sep; 370():111926. PubMed ID: 31029708
[TBL] [Abstract][Full Text] [Related]
19. (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
Cilia J; Hatcher P; Reavill C; Jones DN
J Psychopharmacol; 2007 May; 21(3):302-11. PubMed ID: 17591657
[TBL] [Abstract][Full Text] [Related]
20. Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs.
Basta-Kaim A; Szczęsny E; Leśkiewicz M; Głombik K; Slusarczyk J; Budziszewska B; Regulska M; Kubera M; Nowak W; Wędzony K; Lasoń W
Pharmacol Rep; 2012; 64(6):1400-10. PubMed ID: 23406750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
